Bruker Corporation (NASDAQ:BRKR) – Research analysts at Cantor Fitzgerald issued their FY2016 EPS estimates for Bruker Corporation in a research note issued on Tuesday. Cantor Fitzgerald analyst B. Brokmeier anticipates that the brokerage will post earnings per share of $1.10 for the year. Cantor Fitzgerald currently has a “Buy” rating and a $28.00 price objective on the stock. Cantor Fitzgerald also issued estimates for Bruker Corporation’s FY2017 earnings at $1.12 EPS.

Bruker Corporation (NASDAQ:BRKR) last announced its earnings results on Wednesday, November 2nd. The company reported $0.32 EPS for the quarter, beating analysts’ consensus estimates of $0.20 by $0.12. The company earned $393.90 million during the quarter, compared to the consensus estimate of $394.14 million. Bruker Corporation had a return on equity of 26.05% and a net margin of 9.02%. The firm’s revenue for the quarter was down .6% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.19 earnings per share.

COPYRIGHT VIOLATION WARNING: This article was posted by Watch List News and is the sole property of of Watch List News. If you are viewing this article on another publication, it was stolen and republished in violation of U.S. & international copyright & trademark legislation. The legal version of this article can be viewed at http://www.watchlistnews.com/bruker-corporation-forecasted-to-post-fy2016-earnings-of-1-10-per-share-brkr/1061131.html.

Earnings History and Estimates for Bruker Corporation (NASDAQ:BRKR)

BRKR has been the topic of a number of other research reports. Zacks Investment Research downgraded Bruker Corporation from a “buy” rating to a “hold” rating in a research note on Thursday, October 20th. Barclays PLC downgraded Bruker Corporation from an “overweight” rating to an “equal weight” rating and reduced their price objective for the stock from $30.00 to $22.00 in a research note on Wednesday, January 4th. J P Morgan Chase & Co downgraded Bruker Corporation from an “overweight” rating to a “neutral” rating and reduced their price objective for the stock from $23.00 to $20.00 in a research note on Wednesday, December 14th. Finally, Leerink Swann initiated coverage on Bruker Corporation in a research note on Thursday, November 10th. They issued a “market perform” rating and a $21.00 price objective on the stock. Two investment analysts have rated the stock with a sell rating, twelve have given a hold rating, four have issued a buy rating and one has given a strong buy rating to the stock. The company has an average rating of “Hold” and a consensus target price of $24.85.

Bruker Corporation (NASDAQ:BRKR) opened at 22.77 on Friday. The company’s 50 day moving average price is $22.04 and its 200-day moving average price is $22.41. Bruker Corporation has a one year low of $19.58 and a one year high of $29.85. The company has a market cap of $3.65 billion, a P/E ratio of 25.73 and a beta of 1.02.

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Veritable L.P. raised its position in Bruker Corporation by 0.3% in the second quarter. Veritable L.P. now owns 13,091 shares of the company’s stock valued at $298,000 after buying an additional 33 shares during the last quarter. PNC Financial Services Group Inc. raised its position in Bruker Corporation by 0.3% in the second quarter. PNC Financial Services Group Inc. now owns 17,853 shares of the company’s stock valued at $406,000 after buying an additional 47 shares during the last quarter. Neuberger Berman Group LLC raised its position in Bruker Corporation by 0.3% in the second quarter. Neuberger Berman Group LLC now owns 31,800 shares of the company’s stock valued at $723,000 after buying an additional 81 shares during the last quarter. Seven Eight Capital LLC raised its position in Bruker Corporation by 2.6% in the second quarter. Seven Eight Capital LLC now owns 11,700 shares of the company’s stock valued at $266,000 after buying an additional 300 shares during the last quarter. Finally, Legal & General Group Plc raised its position in Bruker Corporation by 4.1% in the second quarter. Legal & General Group Plc now owns 8,460 shares of the company’s stock valued at $192,000 after buying an additional 335 shares during the last quarter. 67.70% of the stock is owned by hedge funds and other institutional investors.

COPYRIGHT VIOLATION WARNING: This article was posted by Watch List News and is the sole property of of Watch List News. If you are viewing this article on another publication, it was stolen and republished in violation of U.S. & international copyright & trademark legislation. The legal version of this article can be viewed at http://www.watchlistnews.com/bruker-corporation-forecasted-to-post-fy2016-earnings-of-1-10-per-share-brkr/1061131.html.

In other news, Director Ingen Chris Van sold 20,000 shares of the business’s stock in a transaction on Tuesday, December 13th. The stock was sold at an average price of $22.29, for a total value of $445,800.00. Following the completion of the transaction, the director now directly owns 5,000 shares of the company’s stock, valued at approximately $111,450. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, CEO Frank H. Laukien purchased 2,124 shares of Bruker Corporation stock in a transaction dated Friday, November 25th. The stock was bought at an average cost of $22.90 per share, with a total value of $48,639.60. Following the completion of the transaction, the chief executive officer now owns 37,699,606 shares in the company, valued at approximately $863,320,977.40. The disclosure for this purchase can be found here. Company insiders own 35.80% of the company’s stock.

The company also recently announced a quarterly dividend, which was paid on Friday, December 23rd. Shareholders of record on Monday, December 5th were given a dividend of $0.04 per share. This represents a $0.16 dividend on an annualized basis and a yield of 0.70%. The ex-dividend date of this dividend was Thursday, December 1st. Bruker Corporation’s dividend payout ratio (DPR) is presently 18.18%.

Bruker Corporation Company Profile

Bruker Corporation is a designer and manufacturer of scientific instruments, and analytical and diagnostic solutions. The Company’s operating segments include the Bruker BioSpin Group; the Bruker Chemicals, Applied Markets, Life Science, In-Vitro Diagnostics, Detection (CALID) Group; the Bruker Nano Group, and the Bruker Energy & Supercon Technologies (BEST) Segment.

5 Day Chart for NASDAQ:BRKR

Receive News & Ratings for Bruker Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bruker Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.